Albany, NY, June 24, 2016 --(PR.com
)-- MarketResearchHub.com has added a new research report to its rapidly expanding database on the global pharmaceutical industry. “United States MicroRNA Research Tools, Diagnostics and Therapeutics Industry 2016 Market Research Report” is a comprehensive regional analysis of one of the most promising emerging markets in the world. This 131-page report explains the U.S. microRNA research tools, diagnostics, and therapeutics market as it stands currently and how it is expected to shape up in the near future.
MicroRNAs are typically found in animals, plants, and a few types of viruses. They are a core component of gene expression and gene regulation. They function at a post-transcriptional level and are capable of tweaking the protein-encoding genes in mammals by a maximum of 30%. Physically, microRNAs are found in single-strands and are short - a length of nearly 22 nucleotides.
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/united-states-microrna-research-tools-diagnostics-and-therapeutics-industry-2016-market-research-report-report.html
The discovery of microRNA is extremely new to the biology world; its discovery is credited to Victor Ambros and his research team in 1993. This makes the U.S. microRNA research tools, diagnostics, and therapeutics market as well as its global counterpart a nascent stage market.
The aspects of the microRNA market – research, diagnostics, and therapeutics – all hold major importance in various areas of the healthcare and pharmaceutical industries.
MicroRNA tools are used to tackle the challenge of actually identifying the microRNA. There are currently highly advanced tools that researchers can use to understand the highly complex nature and functions of microRNA.
A large number of the total players in the global microRNA market are based in North America, particularly the U.S. This region enjoys a high rate of government funding into the study of microRNA, owing to the high potential that this fields shows in the treatment of currently incurable diseases. Micro-arrays, inhibition, labeling, linear amplification and other forms of technologies are being developed as a result of these government funds.
The U.S. microRNA research tools, diagnostics, and therapeutics market specifically holds a high market share in terms of the global market, owing to the presence of a highly advanced healthcare industry.
The research report considers all the above factors and other relevant ones to calculate the market size of the U.S. microRNA research tools, diagnostics, and therapeutics market for 2016. Other factors included in the market’s research include industry policy analysis and industry news analysis.
The U.S. microRNA research tools, diagnostics, and therapeutics market is also explained in terms of multiple aspects, including the analysis of manufacturing costs, technical information and manufacturing plants, production ratios, consumption volumes, and supplies and sales in the market.
Request for Sample Report with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=S&repid=713111
The key players in the U.S. microRNA research tools, diagnostics, and therapeutics market are Interna Technologies BV, Integrated DNA Technologies, Illumina, HTG, Molecular Diagnostics, Groove Biopharma, Gensignia Life Sciences, Genosensor, Genecopoeia, Fluidigm, Firefly Bioworks, Exiqon A/S, CBC, Bio-Rad Laboratories, Biofire Diagnostics, Asuragen, Applied Biological Materials, Ambion, Agilent Technologies, Alnylam Pharmaceuticals, and Affymetrix.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.